L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
7 active ingredients 7 principios activos 7 个活性成分 7 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Alpelisib
L01EM03active US GB CA SG ES · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG ES MX TW EU · discontinued FR · unknown AU HK - Inavolisib
L01EM06active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Idelalisib
L01EM01active US GB CA AU ES · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA AU ES EU FR - Duvelisib
L01EM04active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · withdrawn EU - 度维利塞
L01EMactive CN
active CN - 伊那利塞
L01EMactive CN
active CN - 林普利塞
L01EMactive CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).